Table 2 Association between clinical and histopathological data and treatment response
Characteristics | No. of patients | CR group | NCR group | p |
|---|---|---|---|---|
| Â | n (%) | n | n | Â |
Study population | 21 (100%) | 12 | 9 | Â |
Age (years) | ||||
Median | 21 | 56.5 | 42 | < 0.01 |
Range | Â | 28-73 | 27-55 | Â |
Tumor size (cm) | ||||
Median | 21 | 4.75 | 5 | 0.054 |
Range | Â | 2.0-6.5 | 2.5-8.0 | Â |
Hemoglobin (g/dl) | ||||
Median | 21 | 12.75 | 12.2 | 0.8 |
Range | Â | 7.9-14.2 | 10.1-14.4 | Â |
FIGO stage | ||||
IIB | 10 (47.62%) | 4 | 6 | 0.62 |
IIIA | 5 (23.81%) | 4 | 1 | Â |
IIIB | 6 (28.57%) | 4 | 2 | Â |
HPV subtype | ||||
16 | 16 (76.19%) | 10 | 6 | - |
Other high-risk | 3 (14.29%) | 1 | 2 | Â |
Negative | 2 (9.52%) | 1 | 1 | Â |